Medtech

CARI Health Raises $2.3M in Seed Round to Advance Remote Medication Monitoring

Retrieved on: 
Tuesday, January 10, 2023

Digital health startup CARI Health has closed an oversubscribed $2.3 million seed round that will help it bring the world’s first wearable real-time medication monitor to market.

Key Points: 
  • Digital health startup CARI Health has closed an oversubscribed $2.3 million seed round that will help it bring the world’s first wearable real-time medication monitor to market.
  • The funding will go toward completing first in-patient human clinical studies for CARI Health’s wearable remote medication monitoring device , expanding its intellectual property portfolio, and preparing for the regulatory pathway with the Food and Drug Administration.
  • “San Diego Angel Conference Fund IV is excited to lead CARI Health’s successful seed round in 2022,” said Mysty Rusk, founder of the SDAC and Executive Director of USD's Free Enterprise Institute.
  • “We are passionate about the potential to make an impact and build something bigger than ourselves,” says CARI Health Founder and CEO Patrik Schmidle .

Lauded Neurosurgeon, Researcher and Inventor Nicholas Theodore, MD Joins Harvard MedTech’s Medical Advisory Board

Retrieved on: 
Tuesday, January 10, 2023

Nationally recognized neurosurgeon Nicholas Theodore, MS, MD, FAANS, FACS has accepted an invitation to join the Medical Advisory Board of Harvard MedTech , announced Gerry Stanley, M.D., Chief Medical Officer at Harvard MedTech.

Key Points: 
  • Nationally recognized neurosurgeon Nicholas Theodore, MS, MD, FAANS, FACS has accepted an invitation to join the Medical Advisory Board of Harvard MedTech , announced Gerry Stanley, M.D., Chief Medical Officer at Harvard MedTech.
  • Theodore is the Director of the Neurosurgical Spine Program at the most prestigious neurosurgical program in the country,” noted Dr. Stanley.
  • “In addition to his surgical innovations and research endeavors, Dr. Theodore holds over 20 patents for medical devices and procedures.
  • The purpose of the Harvard MedTech Medical Advisory Board is to facilitate industry-wide adoption of Vx® Therapy in the treatment of workplace trauma.

Affluent Medical : Affluent Medical strengthens its management team to support industrial and commercial deployment

Retrieved on: 
Thursday, February 2, 2023

Prior to joining Affluent Medical, Claire André held quality management positions in companies developing and marketing class III medical devices.

Key Points: 
  • Prior to joining Affluent Medical, Claire André held quality management positions in companies developing and marketing class III medical devices.
  • Sébastien Ladet, CEO of Affluent Medical, said: "I am delighted that Claire, Olivier and Céline have joined Affluent Medical at a pivotal time in the life of the Group.
  • As we continue the clinical development of our three innovative medical devices, Affluent Medical is actively preparing for the next steps in industrialization and commercial development with a highly experienced and complementary team."
  • Affluent Medical is examining the best financing options to support the next stages of its development.

MediGO Leadership Selected to Speak at 2023 SXSW Conference to Discuss Innovation in Organ Transplant Supply Chains

Retrieved on: 
Tuesday, January 17, 2023

BALTIMORE, Jan. 17, 2023 (GLOBE NEWSWIRE) -- MediGO , a Baltimore-based healthcare supply chain technology company, is pleased to share that co-founder and CEO Scott Plank will serve as a panel moderator at the 2023 SXSW Conference.

Key Points: 
  • BALTIMORE, Jan. 17, 2023 (GLOBE NEWSWIRE) -- MediGO , a Baltimore-based healthcare supply chain technology company, is pleased to share that co-founder and CEO Scott Plank will serve as a panel moderator at the 2023 SXSW Conference.
  • The session , Innovating Organ Transplant Supply Chains with UAS, will take place on Sunday, March 12, at 10 a.m. CST, as part of the conference’s Health and MedTech track.
  • I am thrilled that SXSW has offered us the opportunity to present a timely discussion at the 2023 conference about the future of transporting organs,” said Plank.
  • To attend the session, Innovating Organ Transplant Supply Chains with UAS, register for the 2023 SXSW Conference here .

Global Medical Device Company, PBC BioMed, announces launch of new innovation management tool ‘AIM’

Retrieved on: 
Friday, January 13, 2023

With an established track record of innovation, PBC BioMed has assembled a global team with a deep understanding of the regulatory, quality, clinical and commercial requirements facing innovators based in the EU or US, and wishing to enter new markets.

Key Points: 
  • With an established track record of innovation, PBC BioMed has assembled a global team with a deep understanding of the regulatory, quality, clinical and commercial requirements facing innovators based in the EU or US, and wishing to enter new markets.
  • The Accelerating Innovation Model, or ‘AIM’, is designed to bring new concepts through the product lifecycle stages quickly, will de-risking potential roadblocks along the way.
  • Whether support is required for a specific step, or the entire journey, AIM can help.
  • We are looking forward to working with like-minded people who want to improve healthcare and need to do it quickly!"

Integer to Exhibit at NANS 2023 Annual Meeting

Retrieved on: 
Tuesday, January 10, 2023

PLANO, Texas, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device outsource (MDO) manufacturer, will exhibit at the 26th North American Neuromodulation Society (NANS) Annual Meeting at Caesars Palace Convention Center in Las Vegas, Nevada, from Jan. 12 – 14, 2023, joining medtech leaders and innovators from around the world.

Key Points: 
  • PLANO, Texas, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device outsource (MDO) manufacturer, will exhibit at the 26th North American Neuromodulation Society (NANS) Annual Meeting at Caesars Palace Convention Center in Las Vegas, Nevada, from Jan. 12 – 14, 2023, joining medtech leaders and innovators from around the world.
  • Attendees are invited to visit Integer at booth #525 to learn more about Integer’s breadth and depth of innovative medical device manufacturing, design and development capabilities.
  • This encompasses expanded implantable neuromodulation lead offerings as a result of the acquisition of Oscor in December 2021.
  • During NANS, Integer will unveil its latest innovations and expanded capabilities in neuromodulation to enable the next generation of miniaturized active implantable devices.

Ra Medical Systems Completes Merger with Catheter Precision

Retrieved on: 
Tuesday, January 10, 2023

Ra Medical Systems, Inc. (NYSE American: RMED) (“Ra Medical” or the “Company”) announces the completion of its previously announced stock-for-stock merger transaction with Catheter Precision, Inc., a company focused on the cardiac electrophysiology market.

Key Points: 
  • Ra Medical Systems, Inc. (NYSE American: RMED) (“Ra Medical” or the “Company”) announces the completion of its previously announced stock-for-stock merger transaction with Catheter Precision, Inc., a company focused on the cardiac electrophysiology market.
  • Medtech veteran and Catheter Precision CEO and founder David Jenkins has joined Ra Medical’s Board of Directors as Executive Chairman.
  • Catheter Precision’s product portfolio also includes the Amigo®, a robotic arm that serves as a catheter control device.
  • About the transaction, Mr. Jenkins stated, “We are excited to bring Catheter Precision into a public company environment via the merger with RMED, which allows us access to an additional pool of capital.

4 Greenberg Traurig Texas Attorneys Named to D Magazine 'Best Lawyers Under 40' List

Retrieved on: 
Monday, January 9, 2023

DALLAS, Jan. 9, 2023 /PRNewswire-PRWeb/ -- Four attorneys from global law firm Greenberg Traurig, LLP's Dallas office were selected to D Magazine's 2022 "Best Lawyers Under 40" list, recognizing young lawyers in the North Texas area. Sarah-Michelle Stearns and Allison M. Stewart made their debut on the list this year.

Key Points: 
  • Four attorneys from global law firm Greenberg Traurig, LLP's Dallas office were selected to D Magazine's 2022 "Best Lawyers Under 40" list, recognizing young lawyers in the North Texas area.
  • DALLAS, Jan. 9, 2023 /PRNewswire-PRWeb/ -- Four attorneys from global law firm Greenberg Traurig, LLP's Dallas office were selected to D Magazine's 2022 "Best Lawyers Under 40" list, recognizing young lawyers in the North Texas area.
  • Greenberg Traurig Dallas attorneys selected for 2023 include:
    Basile has more than 15 years of combined experience in the tech and legal industries.
  • The complete list of attorneys will appear in the January 2023 edition of D Magazine and is available online.

FlatTech LLC Receives Innovative Technology Contract from Vizient for EpiFaith(R) Syringe for safer epidurals

Retrieved on: 
Monday, January 9, 2023

TAIPEI, Jan. 9, 2023 /PRNewswire/ -- FlatTech LLC announced its EpiFaith® Syringe for epidural has received an Innovative Technology contract from Vizient, Inc. the nation's largest member-driven health care performance improvement company. The contract was awarded based on the recommendation of EpiFaith® by hospital experts who serve on one of Vizient's member-led councils, and it signifies to Vizient members unique qualities that potentially bring improvement to the health care industry.

Key Points: 
  • TAIPEI, Jan. 9, 2023 /PRNewswire/ -- FlatTech LLC announced its EpiFaith® Syringe for epidural has received an Innovative Technology contract from Vizient, Inc. the nation's largest member-driven health care performance improvement company.
  • Innovative Technology contracts are recommended after review and interaction with products submitted through Vizient's Innovative Technology Program.
  • Through its Innovative Technology Program , Vizient works with member-led councils and task forces to evaluate products for their potential to bring real innovation to health care.
  • Vizient may award a contract to products deemed worthy of the Innovative Technology designation outside of the competitive bid cycle.

SoniVie Raises $60m in Round C Financing, and Appoints New Board Members

Retrieved on: 
Monday, January 9, 2023

TEL AVIV, Israel, Jan. 9, 2023 /PRNewswire/ -- SoniVie Ltd. ("SoniVie" or the "Company"), a medical device company developing a proprietary solution to treat hypertension, announced today the completion of a $60 million series C round financing. The financing was led by Andera Partners, with participation from Supernova Invest and Omega Funds. Current SoniVie shareholder TechWald also participated.

Key Points: 
  • In conjunction with the financing, the Company appointed two renowned medtech experts to its Board of Directors, Raymond W. Cohen and Zeev Zehavi, as independent directors.
  • The proceeds from SoniVie financing are envisioned to be used to reach clinical and regulatory milestones and to support TIVUS™ renal artery denervation program.
  • Raphaël Wisniewski of Andera Partners commented, "SoniVie TIVUS™ has the potential to provide patients and physicians with a safe, efficient and easy to use device.
  • We are thrilled to support this talented management together with our syndicate partners and our new board members".